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The biochemical pathways ofenergy metabolism in
the brain are in most respects like those of other tissues, but special conditions peculiar to the central
nervous system in vivo limit full expression of its
bioclhemical potentialities. In no tissue are the discrepancies between in vivo and in vitro properties
greater or the extrapolations from in vitro data to
conclusions about in vivo metabolic functions more
hazardous. Valid identification of normally used
substrates and products of cerebral energy
metabolism, as well as reliable estimations of their
rates of utilization and production, can be obtained
only in the intact animal; in vitro studies identify
pathways ofintermediary metabolism, mechanisms
and potential rather than actual performance.
Although the brain is said to be unique
among tissues in its high rate of oxidative
metabolism, the overall cerebral metabolic rate
for 0 2 (CMR02 ) is of the same order as the unstressed heart and renal cortex [I). Regional
fluxes in the brain may greatly exceed CMR02,
however, and these are closely coupled to
changes in metabolic demand.

INTERMEDIARY METABOLISM
ATP production in brain is highly regulated
Oxidative steps of carbohydrate metabolism
normally contribute 36 of the 38 high-energy
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CEREBRAL ENERGY METABOLISM IN
PATHOLOGICAL STATES 665
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to anxiety 665
Coma and systemic met abolic diseases depress
brain metabolism 666
Measurement of local cerebral energy metabolism
in humans 667

phosphate bonds (-P) generated during aerobic
metabolism of a single glucose molecule. About
!So/o of brain glucose is converted to lactate and
does not enter the Krebs cycle, also termed the
citric acid cycle. However, this might be
matched by a corresponding uptake of ketone
bodies. The total net gain of-Pis 33 equivalents
per mole of glucose utilized. The steady-state
concentration of ATP is high and represents the
sum of very rapid synthesis and utilization. On
average, half of the terminal phosphate groups
turn over in about 3 sec; this is probably much
faster in certain regions [2]. The level of-Pis
kept constant by regulation of ADP phosphorylation in relation to ATP hydrolysis. The active
adenylyl kinase reaction, which forms equivalent
amounts of ATP and AMP from ADP, prevents
any great accumulation of ADP. Only a small
amount of AMP is present under steady-state
conditions; thus, a relatively small decrease in
ATP may lead to a relatively large increase in
AMP, which is a positive modulator of many reactions that lead to increased ATP synthesis.
Such an amplification factor provides a sensitive
control for maintenance of ATP levels [3). Between 37 and 42°C, the brain metabolic rate increases about So/o per degree.
The concentration of creatine phosphate
(CRP) in brain is even higher than that of ATP,
and creatine phosphokinase (CPK) is extremely
active. The CRP level is exquisitely sensitive to
changes in oxygenation, providing - P for ADP

Chapter 31 Brain Circulation and Metabolism
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phosphorylation and, thus, maintaining ATP
levels. The CPK system also may function in regulating mitochondrial activity. In neurons with a
very heterogeneous mitochondrial distribution,
the CRP shuttle may play a critical role in energy
transport [4]. The BB isoenzyme ofCPK is characteristic of, but not confined to, brain. Thus, its
presence in body fluids does not necessarily indicate disruption of neural tissue.
Glycogen is a dynamic but limited
energy store in brain
Although present in relatively low concentration
in brain (3.3 mmoVkg brain in rat), glycogen is a
unique energy reserve that requires no energy
(ATP) for initiation of its metabolism. As with
glucose, glycogen levels in brain appear to vary
with plasma glucose concentrations. Biopsies
have shown that human brain contains much
more glycogen than rodent brain, but the effects
of anesthesia and pathological changes in the
biopsied tissue may have contributed. Glycogen
granules are seen in electron micrographs of glia
and neurons ofimmature animals but only in astrocytes of adults. Barbiturates decrease brain
metabolism and increase the number of granules
seen, particularly in astrocytes of synaptic regions; however, biochemical studies show that
neurons do contain glycogen and that enzymes
for its synthesis and metabolism are present in
synaptosomes. Astrocyte glycogen may form a
store of carbohydrate made available to neurons
by still undefined mechanisms. Associated with
the granules are enzymes involved in glycogen
synthesis and, perhaps, degradation. The increased glycogen found in areas of brain injury
may be due to glial changes or to decreased utilization during tissue preparation.
The accepted role of glycogen is that of a
carbohydrate reserve utilized when glucose falls
below need. However, rapid, continual breakdown and synthesis of glycogen occur at a rate of
19 IJ.moVkglmin. This is about 2% of the normal
glycolytic flux in brain and is subject to elaborate
control mechanisms. This suggests that, even
under steady-state conditions, local carbohydrate reserves are important for brain function.
However, if glycogen were the sole supply, normal glycolytic flux in brain would be maintained
for less than 5 min.
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The enzymes which synthesize and catabolize glycogen in other tissues are found in
brain also, but their kinetic and regulatory
properties do differ [5). Glycogen metabolism
in brain, unlike in other tissues, is controlled
locally. It is isolated from the tumult of systemic activity, evidently by the blood-brain
barrier (BBB). Although glucocorticoid hormones that penetrate the BBB increase glycogen turnover, circulating protein hormones
and biogenic amines have no effect. Beyond the
BBB, cells are sensitive to local amine concentrations; drugs that cross the BBB and modify
local amine concentrations or membrane receptors thus cause metabolic changes (see
Chap. 32).
Separate systems for the synthesis and
degradation of glycogen provide a greater degree
of control than if glycogen were degraded by
simply reversing its synthesis (Fig. 31-1). The
amount of glucose-6-phosphate ( G6P), the initial synthetic substrate, usually varies inversely
with the rate of brain glycolysis because of
greater facilitation of the phosphofructokinase
step relative to transport and phosphorylation of
glucose. Thus, a decline in G6P during energy
need slows glycogen formation.
The glucosyl group of uridine diphosphoglucose (UDP-glucose) is transferred to the terminal glucose of the nonreducing end of an
amylose chain in an a -1 ,4-glycosidic linkage
(Fig. 31-1). This reaction, catalyzed by glycogen
synthetase (GS), is rate-controlling for glycogen
synthesis [5). In brain, as in other tissues, GS occurs in both a phosphorylated (D) form, which
depends on G6P as a positive modulator, and a
dephosphorylated, independent (I) form sensitive to, but not dependent on, the modulator.
Although in brain the I form of GS requires no
stimulator, it has a relatively low affinity for
UDP-glucose. At times of increased energy demand, not only is there a change from the D to
the I form but also an I form with even lower
affinity for substrate develops. Inhibition of
glycogen synthesis is enhanced, and this increases the availability of G6P for energy needs.
Goldberg and O'Toole [5) hypothesize that the I
form in brain is associated with inhibition of
glycogen synthesis under, conditions of energy
demand, whereas the D form causes a relatively
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FIGURE 31-1. Glycogen metabo lism in brain. Enzyme data from mouse brain ho mogenates. Numerals below each
enzyme represent maximal velocity WmaJ at 38°C in millimoles per kilogram wet weight per minute; metabolite concentrations from quick-frozen adult mouse brain are in micromoles per kilogram wet weight. P-P, pyrophosphate.
(Metabolic data from [41 ); enzyme data from [42]).

small regulated synthesis under resting conditions. Regulation of the D form may reduce
glycogen formation in brain to approximately
5% of its potential rate. In liver, where large
amounts of glycogen are synthesized and degraded, the I form of GS is associated with glycogen formation. At present, it appears that the
two tissues use the same biochemical apparatus
in different ways to bring about their different
overall metabolic patterns.
Under steady-state conditions, it is proba-

ble that Jess than 10% of phosphorylase in brain
(Fig. 31-1) is in the unphosphorylated b form
(requiring AMP), which is inactive at the very
low AMP concentrations present normally.
When a steady state is disturbed, there may be
an extremely rapid conversion of enzyme to the

a form, which is active at low AMP. Brain phosphorylase b kinase is activated indirectly by
cAMP and by the molar concentrations of Ca2 +

released during neuronal excitation (see Chap.
22) . The endoplasmic reticulum of brain, like
Ca 2 +

muscle, is capable of taking up
to terminate its stimulatory effect. These reactions provide energy from glycogen during excitation
and when cAMP-forming systems are acti vated. It has not been possible to confirm di-

reedy that the conversion from phosphorylase
b to a is a control point of glycogenolysis in
vivo. Norepinephrine and, probably, dopamine
activate glycogenolysis through cAMP; but
epinephrine, vasopressin and angiotensin II do
so by another mechanism, possibly involving
Ca 2 + or a Ca 2 + -mediated proteolysis of phos-

phorylase kinase.
Hydrolysis of the u-1,4-glycoside linkages
leaves a limit dextrin that turns over at only half

the rate of the outer chains (see also Chap. 42).
The debrancher enzyme that hydrolyzes the u1,6-glycoside linkages may be rate-limiting if the
entire glycogen granule is utilized. Because one
product of this enzyme is free glucose, approxi-

mately one glucose molecule for every 11 of G6P
is released if an entire glycogen molecule is degraded (Fig. 31-1). a-Glucosidase, also termed
acid maltase, is a lysosomal enzyme whose precise function in glycogen metabolism is not

known. In Pompe's disease, which is the hereditary absence of ex -glucosidase, glycogen accumulates in brain as well as elsewhere (see Chap. 42).

The steady-state concentration of glycogen is
regulated precisely by the coordination of synthetic and degradative processes through enzymatic regulation at several metabolic steps [6].

Chapter 31

Brain glycolysis is regulated mainly by
hexokinase and phosphofructokinase

Aerobic and anaerobic glycolysis have been defined historically as the amount of lactate produced under conditions of "adequate" oxygen
and no oxygen, respectively. More recently, glycolysis refers to the Embden-Meyerhoff glycolytic
sequence from glucose, or glycogen glucosyl, to
pyruvate. Glycolytic flux is defined indirectly: it is
the rate at which glucose must be utilized to produce the observed rate of ADP phosphorylation.
Figure 31-2 outlines the flow of glycolytic
substrates in brain. Glycolysis first involves
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Lactic dehydrogenase
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phosphorylation by hexokinase. The reaction is
essentially irreversible and is a key point in the
regulation of carbohydrate metabolism in brain.
The electrophoretically slow-moving (type I)
isoenzyme of hexokinase is characteristic of
brain. In most tissues, hexokinase may be soluble and may exist in the cytosol or be attached
firmly to mitochondria. Under conditions in
which no special effort is made to stop
metabolism while isolating mitochondria, 80 to
90% of brain hexokinase is bound. In the live
steady state, however, when availability of substrate keeps up with metabolic demand and end
products are removed, an equilibrium exists be-
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FIGURE 31-2. Glycolysis in brain. Enzyme and metabolic data expressed as in Figure 31-1 . *Ten-day-old mouse
brain [43]. (Data from [44].)
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tween the soluble and the bound enzyme. Bind-

of liver and brain can be related to the function

ing changes the kinetic properties of hexokinase

of liver as a carbohydrate storehouse for the

and its inhibition by G6P so that the bound enzyme on mitochondria is more active. The extent of binding is inversely related to the ATP:
ADP ratio, so conditions in which energy utilization exceeds supply shift the solubilization equilibrium to the bound form and produce a greater
potential capacity for initiating glycolysis to
meet the energy demand. This mechanism allows ATP to function both as the substrate of the
enzyme and, at another site, as a regulator to decrease ATP production through its influence on
enzyme binding. It also confers preference on
glucose in the competition for the MgATP 2 ~

body, whereas brain metabolism is adapted for
rapid carbohydrate utilization for energy needs.

In glycolysis, G6P is the substrate of phosphohexose isomerase. This is a reversible reaction,

with a small free energy change and a 5:1 equilibrium ratio in brain that favors G6P.
Fructose-6-phosphate is the substrate of
phosphofructokinase, a key regulatory enzyme
controlling glycolysis [3]. The other substrate is
MgATP 2 ~ . Like other regulatory reactions, it is
essentially irreversible. It is modulated by a large
number of metabolites and cofactors, whose concentrations under different metabolic conditions

generated by mitochondrial oxidative phosphorylation. Thus, a process that will sustain ATP
production continues at the expense of other

have a great effect on glycolytic flux. Prominent
among these are availability of - P and citrate

uses of energy. Because energy reserves are ex-

hibited by ATP, Mg2+ and citrate and stimulated
by NH!, K+, PO~~. 5'-AMP, 3',5',-cAMP, ADP
and fructose-1,6-bisphosphate.
When oxygen is admitted to cells metaboliz-

hausted rapidly postmortem, it is not surprising
that brain hexokinase is bound almost entirely.
The significance of reversible binding of
other enzymes to mitochondria is not clear. The

measured glycolytic flux, when compared with
the maximal velocity of hexokinase, indicates

concentrations. Brain phosphofructokinase is in-

ing anaerobically, utilization of 0 2 increases,
whereas utilization of glucose and production of
lactate drop; this is known as the Pasteur effect.

that in the steady state the hexokinase reaction is

Modulation of the phosphofructokinase reaction

inhibited 97%. Brain hexokinase is inhibited by
its product G6P, to a lesser extent by ADP and allosterically by 3-phosphoglycerate and several
nucleoside phosphates, including cAMP and
free ATP 4 ~ . The ratio of ATP to Mg>+ also may

can account direcdy for the Pasteur effect. In the
steady state, ATP and citrate concentrations in

have a regulatory action. In addition to acting on
enzyme kinetics, G6P solubilizes hexokinase,

brain apparently are sufficient to keep phosphofructokinase relatively inhibited as long as the
concentration of positive modulators, or disin-

hibitors, is low. When the steady state is disturbed, activation of this enzyme produces an in-

thus reducing the efficiency of the enzyme when

crease in glycolytic flux, which takes place almost

the reaction product accumulates. The sum total
of these mechanisms is a fine tuning of the activ-

as fast as events changing the internal "milieu.

ity of the initial enzyme in glycolysis in response
to changes in the cellular environment. Glucokinase, also termed low-affinity hexokinase, a
major component of liver hexokinase, has not
been found in brain.
G6P represents a branch point in
metabolism because it is a common substrate for

enzymes involved in glycolytic, pentose phosphate shunt and glycogen-forming pathways.
There is also slight but detectable G6Pase activity in brain, the significance of which is not clear.
The liver requires this enzyme to convert glyco-

gen to glucose. The differences between the hexokinases and the modes of glycogen metabolism

Fructose-1,6-bisphosphate is split by brain
aldolase to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. Dihydroxyacetone

phosphate is the common substrate for both
glycerophosphate dehydrogenase, an enzyme
active in reduced nicotinamide adenine dinu-

cleotide (NADH) oxidation and lipid pathways
(see Chap. 3), and triose phosphate isomerase,
which maintains an equilibrium between dihydroxyacetone phosphate and glyceraldehyde-3phosphate; the equilibrium strongly favors accumulation of dihydroxyacetone phosphate.
After the reaction with glyceraldehyde-3phosphate dehydrogenase, glycolysis in brain
proceeds through the usual steps. Brain enolase,

Chapter 31

Brain Circulation and Metabolism

also termed D-2-phosphoglycerate hydrolyase,
which catalyzes dehydration of 2-phosphoglycerate to phosphoenolpyruvate, is present as two

related dimers, one of which (-y) is associated
specifically with neurons and the other (a) with
glia. The neuronal subunit is identical to the
neuron-specific protein 14-3-2. Immunocytochemical determination of the enolases makes
them useful in determining neuron:glia ratios in
tissue samples, but neuron-specific enolase is
not confined to neural tissue. Brain phosphoenolpyruvate kinase controls an essentially irreversible reaction that requires not only Mg2 + , as

do several other glycolytic enzymes, but also K+
or Na+. This step also maybe regulatory.
Brain tissue, even when at rest and well oxygenated, produces a small amount of lactate,
which is removed in the venous blood, account-

ing for 13% of the pyruvate produced by glycolysis. The measured lactate concentration in
brain depends on success in rapidly arresting
brain metabolism prior to tissue processing. Five
lactate dehydrogenase isoenzymes are present in

adult brain; the one that electrophoretically
moves most rapidly toward the anode, termed
band 1, predominates. This isoenzyme is generally higher in tissues that are more dependent on
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sis that participates in cytoplasmic oxidation of

NADH. This enzyme reduces dihydroxyacetone
phosphate to glycerol-3-phosphate, oxidizing
NADH in the process. Under hypoxic conditions, a.-glycerophosphate and lactate increase

initially at comparable rates, although the
amount of lactate produced greatly exceeds that
of a-glycerophosphate. The relative concentrations of the oxidized and reduced substrates of

these reactions indicate much higher local concentrations ofNADH in brain than are found by
gross measurements. In fact, the relative propor-

tions of oxidized and reduced substrates of the
reactions that are linked to the pyridine nu-

cleotides may be a better indicator oflocal redox
states (NAD +/NADH) in brain than the direct
measurement of pyridine nucleotides them-

selves [3,7].
An aspect of glucose metabolism that has
led to much confusion is the observation that la-

beled glucose appears in carbon dioxide much
more slowly than might be suggested from an
examination of the glycolytic pathway plus the
citric acid cycle [8]. Glucose flux is 0.5 to 1.0
jJ.mol/min/g wet weight of brain in a variety of
species. The concentration of glycolytic plus
Krebs cycle intermediates is 2 IJ.mol/g. Hence,

aerobic processes for energy; the slower moving
isoenzymes are relatively higher in tissues such

the intermediates might turn over every 2 to 4

as white skeletal muscle, which is better adapted
to function at suboptimal oxygen levels. The distribution of lactate dehydrogenase isoenzymes

state in 5 to 10 min. This is not seen experimen-

in various brain regions, layers of the retina,
brain neoplasms and brain tissue cultures and
during development indicates that their synthesis might be controlled by tissue oxygen concentrations. Lactate dehydrogenase functions in the

(70 to 80%) from 10 to 30 min after a glucose injection. This is due to high transaminase activity
in comparison with flux through the Krebs cycle,
and amino acids made by transamination of cy-

cytoplasm to oxidize NADH, which accumulates
as a result of the activity of glyceraldehyde-3phosphate dehydrogenase in glycolysis. This
permits glycolytic ATP production to continue

min and 14 C0 2 production might reach a steady
tally. Also, large amounts of radioactivity are
trapped in amino acids related to the Krebs cycle

cle intermediates behave as if they are part of the
cycle. When pools of these amino acids
( - 20 IJ.mol/g) are added to the Krebs cycle components plus glycolytic intermediates, the calculated time for 14 C0 2 evolution is increased by a

under anaerobic conditions. Lactate dehydrogenase also functions under aerobic conditions because NADH cannot easily penetrate mitochon-

sults.

drial membranes. Oxidation of NADH in the
cytoplasm depends on this reaction and on the

the Krebs cycle are present at much lower
steady-state values, and approximately 20% of

activity of shuttle mechanisms that transfer reducing equivalents to mitochondria.

the radioactivity from administered glucose is

Glycerol phosphate dehydrogenase is another enzyme indirectly associated with glycoly-

factor of 10, in agreement with experimental reIn contrast, in liver, amino acids related to

trapped in these amino acids shortly after injection. Thus, ignoring the radioactivity trapped in
amino acids has a relatively small effect on esti-
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mates of glycolytic fluxes in liver but makes an
enormous difference in brain. Immature brain
resembles liver more nearly in this respect. The

relationship of the Krebs cycle to glycolysis undergoes a sharp change during development, coincident with the metabolic compartmentation

of amino acid metabolism characteristic of adult
brain.
The pyruvate dehydrogenase complex
plays a key role in regulating oxidation

Metabolism

acetyl-CoA produced within it, but there is efflux of its condensation product, citrate. Acetyl-

CoA can then be formed from citrate in the cytosol by ATP citrate lyase. The acetyl moiety of
acetylcholine is formed in a compartment, pre-

sumably the synaptosome, with rapid glucose
turnover. The cytosol of cholinergic endings is
rich in citrate lyase, and it is possible that citrate

shuttles the acetyl-CoA from the mitochondrial
compartment to the cytosol. During hypoxia or
hypoglycemia, acetylcholine synthesis can be inhibited by failure of the acetyl-CoA supply.

Pyruvate dehydrogenase has an activity of 14
nmol/min/mg protein in rat brain and controls

the rate of pyruvate entry into the Krebs cycle as
acetyl coenzyme A (acetyl-CoA). Pyruvate dehy-

Energy output and oxygen consumption
are associated with high rates of
enzyme activity in the Krebs cycle

drogenase, or decarboxylase, is part of a mito-

chondrial multienzyme complex that also includes the enzymes lipoate acetyltransferase and
lipoamide dehydrogenase; the coenzymes thiamine pyrophosphate, lipoic acid, CoA and
flavine; and nicotinamide adenine dinucleotides. It is inactivated by being phosphorylated at the decarboxylase moiety by a tightly
bound Mg2 + /ATP 2 - -dependent protein kinase
and activated by being dephosphorylated by a
loosely bound Mg2+ - and Ca2+ -dependent
phosphatase. About half the brain enzyme is
usually active. Pyruvate protects the complex

The actual flux through the Krebs cycle depends
on glycolysis and acetyl-CoA production, which
can "push" the cycle, the possible control at several enzymatic steps of the cycle and the local

by inhibiting the kinase.

in the cytoplasm and requires nicotinamide ade-

against inactivation

ADP concentration, which is a prime activator

of the mitochondrial respiration to which the
Krebs cycle is linked. The steady-state concentration of citrate in brain is about one-fifth that

of glucose. This is relatively high compared with
glycolytic intermediates or isocitrate.
As in other tissues, there are two isocitrate

dehydrogenases in brain. One is active primarily

ADP is a competitive inhibitor of Mg2+ for the

nine dinucleotide phosphate (NADP+) as cofac-

inactivating kinase. Under conditions of greater
metabolic demand, increases in pyruvate and

tor; the other, bound to mitochondria and requiring NAD+, is the enzyme that participates in

ADP and decreases in acetyl-CoA and ATP make
the complex more active. Pyruvate dehydrogenase is inhibited by NADH, decreasing formation of acetyl-CoA during hypoxia and allowing
more pyruvate to be reduced by lactate dehydrogenase, thus forming the NAD+ necessary to
sustain glycolysis. Pyruvate dehydrogenase defects do occur in several mitochondrial enzyme-

deficiency states (see below and Morgan-Hughes
[9], also Chap. 42).
Although acetylcholine synthesis normally
is controlled by the rate of choline uptake and
choline acetyltransferase activity (see Chap. II),
the supply of acetyl-CoA can be limiting under
adverse conditions. Choline uptake is, however,

independent of acetyl-CoA concentration. The
mitochondrial membrane is not permeable to the

the citric acid cycle. The NAD+ -linked enzyme
catalyzes an essentially irreversible reaction, has
allosteric properties, is inhibited by ATP and

NADH and may be stimulated by ADP. The
function of cytoplasmic NADP+ isocitrate dehydrogenase is uncertain, but it has been postu-

lated that it supplies the NADPH necessary for
many reductive synthetic reactions. The rela-

tively high activity of this enzyme in immature
brain and white matter is consistent with such a

role. a-Ketoglutarate (a-KG) dehydrogenase,
which oxidatively decarboxylates a-KG, requires
the same cofactors as does the pyruvate decar-

boxylation step.
Succinate dehydrogenase, the enzyme that
catalyzes the oxidation of succinate to fumarate,

is bound tightly to the mitochondrial mem-
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brane. In brain, succinate dehydrogenase also
may have a regulatory role when the steady state
is disturbed. Isocitrate and succinate concentrations in brain are affected little by changes in the
flux of the citric acid cycle as long as an adequate
glucose supply is available. The highly unfavorable free energy change of the malate dehydrogenase reaction is overcome by the rapid removal
of oxaloacetate, which is maintained at low concentrations under steady-state conditions by the
condensation reaction with acetyl-CoA [6].
Malic dehydrogenase is one of several enzymes in the citric acid cycle present in both the
cytoplasm and mitochondria. The function of
the cytoplasmic components of these enzyme activities is not known, but they may assist in the
transfer of hydrogen equivalents from the cytoplasm into mitochondria.
The Krebs cycle functions as an oxidative
process for energy production and as a source of
various amino acids, for example, glutamate, glutamine, "(-aminobutyrate (GABA), aspartate and
asparagine. To export net amounts of a-KG or
oxaloacetate from the Krebs cycle, the supply of
dicarboxylic acids must be replenished. The major route for this seems to be the fixation of C02
to pyruvate or other substrates at the three-carbon level. Thus, the C02 fixation rate sets an upper limit at which biosynthetic reactions can occur. In studies of acute ammonia toxicity in cats,
this has been estimated as 0.15 IJ.mol/g wet weight
brain/min, or approximately 10% of the flux
through the citric acid cycle (see below). Liver
seems to have ten times the capacity of brain for
C0 2 fixation, as is appropriate for an organ geared
to making large quantities of protein for export
[10]. In brain, pyruvate carboxylase, which catalyzes C02 fixation, appears to be largely an astrocytic enzyme. Pyruvate dehydrogenase seems to
be the rate-limiting step for the entry of pyruvate
into the Krebs cycle from glycolysis.

The pentose shunt, also termed the
hexose monophosphate pathway, is
active in brain
Under basal conditions 5 to 8% of brain glucose
is likely to be metabolized via the pentose shunt
in the adult monkey and 2.3% in the rat [8].
Both shunt enzymes and metabolic flux have
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been found in isolated nerve endings. The penlose pathway has relatively high activity in developing brain, reaching a peak during myelination. Its main contribution is probably to
produce the NADPH needed for reductive reactions necessary for lipid synthesis (see Chap. 3).
Shunt enzymes and metabolic flux are found in
synaptosomes. Although the capacity of the
pathway, as determined using nonphysiological
electron acceptors, remains constant throughout the rat life span, activity with physiological
acceptors could not be detected in middle-aged
(18 months) and older animals. It seems that the
shunt serves as a reserve pathway for use under
such stresses as the need for increased lipid synthesis or repair or reduction of oxidative toxins.
The shunt pathway also provides pentose for nucleotide synthesis; however, only a small fraction
of the activity of this pathway would be required.
As with glycogen synthesis, turnover in the penlose phosphate pathway decreases under conditions of increased energy need, for example, during and after high rates of stimulation. Pentose
phosphate flux apparently is regulated by the
concentrations of G6P, NADP +, glyceraldehyde-3-phosphate and fructose-6-phosphate.
Since transketolase, an enzyme in this pathway,
requires thiamine pyrophosphate as a cofactor,
poor myelin maintenance in thiamine deficiency
may reflect failure of this pathway to provide
sufficient NADPH for lipid synthesis [6].

Glutamate in brain is compartmented
into separate pools
The pools that subserve different metabolic pathways for glutamate equilibrate with each other
only slowly. This compartmentation is a vital factor in the separate regulation of special functions
of glutamate (see Chap. 15) and GABA (see
Chap. 16), such as neurotransmission, and of
general functions, such as protein biosynthesis.
Glutamate metabolism in brain shows at least
two distinct pools; in addition, the Krebs cycle intermediates associated with these pools are distinctly compartmented. Mathematical models to
fit data from radiotracer experiments that require separate Krebs cycles to satisfy the hypotheses of compartmentation have been developed. A
key assumption of current models is that GABA

646

Part Five

Metabolism

is metabolized at a site different from its synthe-

substrates, which are not taken up into brain ef-

sis. The best fit of kinetic data is obtained when

ficiently, appear to be more readily taken up or
activated, or both, in glia. This is believed to lead
to the observed abnormal glutamine/glutamate
ratio. Similarly, metabolic inhibitors, like fluoro-

glutamate from a small pool actively converted to

glutamine flows back to a larger pool (8 f).mol/g),
which is converted to GABA. Of possible relevance to this is the finding that glutamate decarboxylase (GAD) is localized at or near nerve terminals, whereas GABA transaminase, the major

degradative enzyme, is mitochondrial.
Evidence points to an inferred small pool of
glutamate (2 fJ.mol/g) as probably glial. Glutamate released from nerve endings appears to be

taken up by glia or neurons, converted to glutamine and recycled to glutamate and GABA
(see Chaps. 5 and 15). Various estimates of the
proportion of glucose carbon that flows through
the GABA shunt have been made, but the most
definitive experiments show this to be about
10% of the total glycolytic flux. While this may
seem small, that portion of the Krebs cycle flux
used for energy production, including ATP synthesis and maintenance of ionic gradients, does
not require C0 2 fixation, while the portion used

for biosynthesis of amino acids does. Recycling
the carbon skeleton of some of the glutamate released in neurotransmission through glutamine

and GABA to succinate diminishes the need for
dicarboxylic acids to replenish intermediates of

the Krebs cycle when export of ct-KG to make
amino acids takes place.
It is difficult to get good estimates of the extent of C0 2 fixation in brain; the maximum capability measured during ammonia stress, when
glutamine increases rapidly, suggests that C02

fixation occurs at 0.15 f.Lmol/g/min in cat and
0.33 J.l.mol!glmin in rat; this is about the same

rate as for the GABA shunt.
For comparison, only about 2o/o of the glucose flux in whole brain goes toward lipid synthesis and approximately 0.3% is used for protein
synthesis. Thus, turnover of neurotransmitter
amino acids is a major biosynthetic activity in

acetate, appear to act selectively in glia and to
produce their neurotoxic action without marked

inhibition of the overall Krebs cycle flux in brain.
This difference in behavior has led to suggestions
that acetate and fluoroacetate may be useful

markers for the study of glial metabolism by autoradiography [II] .
A nonuniform distribution of metabolites in

living systems is a widespread occurrence. Steadystate concentrations of GABA vary from 2 to 10
mM

in discrete brain regions, and it has been esti-

mated that GABA may be as high as 50 mM in
nerve terminals. Observations in brain indicate the

existence of pools of metabolites with half-lives of
many hours for mixing, which is most unusual.

The discovery of subcellular, morphological compartmentation, that is, different populations of
mitochondria in cerebral cortex that have distinctive enzyme complements, may provide a some-

what better perspective by which to visualize such
a separation of metabolic function [ 12].
In addition to the phasic release of both excitatory and inhibitory transmitters, there may be
a continuous tonic release of GABA, dependent

only on the activity of the enzyme responsible for
its synthesis and independent of the depolarization of the presynaptic membrane. Such inhibitory neurons could act tonically by constantly
maintaining an elevated threshold in the excitatory neurons so that the latter would start firing
when a decrease occurred in the continuous release of GABA acting on them. This is consistent
with a known correlation between the inhibition
of GAD and the appearance of convulsions after

certain drug treatments. GABA is depleted by
some convulsant drugs and elevated by others.

brain.
Metabolic compartmentation of glutamate

usually is observed when labeled ketogenic sub-

DIFFERENCES BETWEEN IN VITRO
AND IN VIVO BRAIN METABOLISM

strates are administered to animals. It is interest-

ing that acetoacetate and 13-hydroxybutyrate do
not show this effect, apparently because ketone

In addition to the usual differences between in
vitro and in vivo studies that pertain to all tissues,

bodies are a normal substrate for brain and are

there are two unique conditions that pertain
only to the central nervous system.

taken up in all kinds of cells. Acetate and similar
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In contrast to cells of other tissues,
individual nerve cells do not function
autonomously
They are generally so incorporated into a complex neural network that their functional activity
is integrated with that of various other parts of
the central nervous system and with somatic tissues. In addition, neurons and adjacent glia are
linked in their metabolism. Any procedure that
interrupts the structural and functional integrity
of the network inevitably would alter quantitatively and, perhaps, qualitatively its normal
metabolic behavior.

The blood-brain barrier selectively limits
the rates of transfer of soluble
substances between blood and brain
This barrier discriminates among various potential substrates for cerebral metabolism (see
Chap. 32). The substrate function is confined
to those compounds in the blood that are not
only suitable substrates for cerebral enzymes
but also can penetrate from blood to brain at
rates adequate to support the considerable energy demands of brain. Substances that can be
readily oxidized by brain slices, minces or homogenates in vitro and that are utilized effectively in vivo when formed endogenously
within the brain often are incapable of supporting cerebral energy metabolism and function
when present in the blood because of restricted
passage through the BBB. The in vitro techniques establish only the existence and potential capacity of the enzyme systems required for
the use of a given substrate; they do not define
the extent to which such a pathway actually is
used in vivo. This can be done only in intact animals, and it is this aspect of cerebral
metabolism with which this part of the chapter
is concerned.

CEREBRAL ENERGY METABOLISM
IN VIVO
Numerous methods have been used to study
the metabolism of the brain in vivo; these vary
in complexity and in the degree to which they
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yield quantitative results. Some require such
minimal operative procedures on the laboratory animal that no anesthesia is required, and
there is no interference with the tissue except
for the effects of the particular experimental
condition being studied. Some of these techniques are applicable to normal, conscious human subjects, and consecutive and comparative
studies can be made repeatedly in the same subject. Other methods are more traumatic and either require the animal to be killed or involve
such extensive surgical intervention and tissue
damage that the experiments approach an in
vitro experiment carried out in situ. All, however, are capable of providing specific and useful information.

Behavioral and central nervous system
physiology are correlated with blood
and cerebrospinal fluid chemical
changes
The simplest way to study the metabolism of the
central nervous system in vivo is to correlate
spontaneous or experimentally produced alterations in the chemical composition of the blood,
spinal fluid or both with changes in cerebral
physiological functions or gross central nervous
system-mediated behavior. The level of consciousness, the reflex behavior or the electroencephalogram (EEG) generally is used to monitor
the effects of chemical changes on functional
and metabolic activities of brain. Such methods
first demonstrated the need for glucose as a substrate for cerebral energy metabolism; hypoglycemia produced by insulin or other means altered various parameters of cerebral function
that could not be restored to normal by administering substances other than glucose.
The chief virtue of these methods is their
simplicity, but they are gross and nonspecific
and do not distinguish between direct effects of
the agent on cerebral metabolism and those secondary to changes produced initially in somatic
tissues. Also, negative results are often inconclusive, for there always remain questions of insufficient dosage, inadequate cerebral circulation
and delivery to the tissues or impermeability of
the BBB.
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Brain samples are removed for
biochemical analyses
The availability of analytical chemical techniques
makes it possible to measure specific metabolites
and enzyme activities in brain tissue at selected
times during or after exposure of the animal to an
experimental condition. This approach has been

very useful in studies of the intermediary
metabolism of brain. It has permitted estimation
of the rates of flux through the various steps of established metabolic pathways and the identification of control points in the pathways where regulation may be exerted. Such studies have helped

to define more precisely changes in energy
metabolism associated with altered cerebral
functions, for example, those produced by anesthesia, convulsions or hypoglycemia. While such
methods require killing animals and analyzing
tissues, in effect, they are in vivo methods since
they attempt to describe the state of the tissue
while it is still in the animal at the moment of
killing. They have encountered their most serious
problems with regard to this point. Postmortem
changes in brain are extremely rapid and not always retarded completely even by the most rapid
freezing techniques available. These methods
have proved to be very valuable, nevertheless,
particularly in the area of energy metabolism.

Radioisotope incorporation can identify
and measure routes of metabolism
The technique of administering radioactive precursors followed by the chemical separation and
assay of products in the tissue has added greatly
to the armamentarium for studying cerebral
metabolism in vivo. Labeled precursors are administered by any of a variety of routes; at selected later times the brain is removed, the precursor and the various products of interest are
isolated and the radioactivity and quantity of the
compounds in question are assayed. Such techniques facilitate identification of metabolic
routes and rates of flux through various steps of
a pathway. In some cases, comparison of specific
activities of the products and precursors has led
to the surprising finding of higher specific activities in products than in precursors. This is conclusive evidence of the presence of compartmen-
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tation. These methods have been used effectively
in studies of amine and neurotransmitter synthesis and metabolism, lipid metabolism, protein synthesis, amino acid metabolism and the
distribution of glucose carbon through the various biochemical pathways present in brain.
Radioisotope incorporation methods are
particularly valuable for studies of intermediary
metabolism, which generally are not feasible by
most other in vivo techniques. They are without
equal for the qualitative identification of the
pathways and routes of metabolism. They suffer,
however, from a disadvantage: only one set of
measurements per animal is possible because the
animal must be killed. Quantitative interpretations often are confounded by the problems of
compartmentation. Also, all too frequently, they
are misused; unfortunately, quantitative conclusions are drawn incorrectly based on radioactivity data without appropriate consideration of the
specific activities of precursor pools.

Oxygen utilization in the cortex is
measured by polarographic techniques
The 0 2 electrode has been used for measuring the
amount of 0 2 consumed locally in the cerebral
cortex in vivo [13). The electrode is applied to the
surface of the exposed cortex, and the local partial
pressure for 0 2 (P0 2 ) is measured continuously
before and during occlusion of the blood flow to
the local area. During occlusion, P0 2 falls linearly
as 0 2 is consumed by tissue metabolism, and the
rate of fall is a measure of the rate of 0 2 consumption locally in the cortex. Repeated measurements can be made successively in the animal,
and the technique has been used to demonstrate
the increased 0 2 consumption of the cerebral cortex and the relation between changes in the EEG
and the metabolic rate during convulsions [13).
The technique is limited to measurements in the
cortex and, of course, to 0 2 utilization.

Arteriovenous differences identify
substances consumed or produced by
brain
The primary functions of the circulation are to
replenish the nutrients consumed by the tissues
and to remove the products of their metabolism.
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These functions are reflected in the composition
of the blood traversing the tissue. Substances
taken up by a tissue from the blood are higher in
concentration in the arterial inflow than in the
venous outflow, and the converse is true for substances released by the tissue. The convention is
to subtract the venous concentration from the
arterial concentration so that a positive arteriovenous difference represents net uptake and a
negative difference, net release. In nonsteady
states, as after a perturbation, there may be transient arteriovenous differences that reflect
changes in tissue concentrations and re-equilibration of the tissue with the blood. In steady
states, in which it is presumed that the tissue
concentration remains constant, positive and
negative arteriovenous differences mean net
consumption or production of the substance by
the tissue, respectively. Zero arteriovenous differences indicate neither consumption nor production.
This method is useful for all substances in
blood that can be assayed with enough accuracy,
precision and sensitivity to enable the detection
of arteriovenous differences. The method is useful only for tissues from which mixed representative venous blood can be sampled. Arterial
blood has essentially the same composition
throughout and can be sampled from any artery.
In contrast, venous blood is specific for each tissue, and to establish valid arteriovenous differences the venous blood must represent the total
outflow or the flow-weighted average of all of the
venous outflows from the tissue under study,
uncontaminated by blood from any other tissue.
It is not possible to fulfill this condition for many
tissues.
The method is fully applicable to the brain,
particularly in humans, in whom the anatomy of
venous drainage is favorable for such studies.
Representative cerebral venous blood, with no
more than approximately 3o/o contamination
with extracerebral blood, is readily obtained from
the superior bulb of the internal jugular vein in
humans. The venipuncture can be made percutaneously under local anesthesia; therefore, measurements can be made during conscious states
undistorted by the effects of general anesthesia.
Using this method with monkeys is similar, although the vein must be exposed surgically before

puncture. Other common laboratory animals are
less suitable because extensive communication
between cerebral and extracerebral venous beds is
present and uncontaminated representative venous blood is difficult to obtain from the cerebrum without major surgical intervention. In
these cases, one can sample blood from the confluence of the sinuses, also termed the torcular
herophili, even though it does not contain fully
representative blood from the brainstem and
some of the lower portions of the brain.
The chief advantages of these methods are
their simplicity and applicability to unanesthetized humans. They permit the qualitative
identification of the ultimate substrates and
products of cerebral metabolism. They have no
applicability, however, to those intermediates
that are formed and consumed entirely within
brain without being exchanged with blood or to
those substances that are exchanged between
brain and blood with no net flux in either direction. Furthermore, they provide no quantification of the rates of utilization or production because arteriovenous differences depend not only
on the rates of consumption or production by
the tissue but also on blood flow (see below).
Blood flow affects all of the arteriovenous differences proportionately, however, and comparison of the arteriovenous differences of various
substances obtained from the same samples of
blood reflects their relative rates of utilization or
production.

Combining cerebral blood flow and
arteriovenous differences permits
measurement of rates of consumption
or production of substances by brain
In a steady state, the tissue concentration of any
substance utilized or produced by brain is presumed to remain constant. When a substance is
exchanged between brain and blood, the difference in its steady state of delivery to brain in the
arterial blood and removal in the venous blood
must be equal to the net rate of its utilization or
production by brain. This relation can be expressed as follows:

CMR

= CBF(A -

V)
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where (A - V) is the difference in concentration
in arterial and cerebral venous blood, CBF is the
rate of cerebral blood flow in volume of blood
per unit time and cerebral metabolic rate (CMR)
is the steady-state rate of utilization or production of the substance by brain.
If both the rate of cerebral blood flow and
the arteriovenous difference are known, then the
net rate of utilization or production of the substance by brain can be calculated. This has been
the basis of most quantitative studies of cerebral
metabolism in vivo.
The most reliable method for determining
cerebral blood flow is the inert gas method of
Kety and Schmidt [14]. Originally, it was designed for use in studies of conscious, unanesthetized humans, and it has been employed most
widely for this purpose; but it also has been
adapted for use in animals. The method is based
on the Fick principle, which is an equivalent of
the law of conservation of matter; and it utilizes
low concentrations of a freely diffusible, chemically inert gas as a tracer substance. The original
gas was nitrous oxide, but subsequent modifications have substituted other gases, such as 85 Kr,
79 Kr or hydrogen, which can be measured more
conveniently in blood. During a period of inhalation of 15% N 2 0 in air, for example, timed
arterial and cerebral venous blood samples are
withdrawn and analyzed for their N 2 0 contents.
The cerebral blood flow in milliliters per 100 g of
brain tissue per minute can be calculated from
the following equation:
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of inhalation is required to approach equilibrium. At the end of this interval, the N 2 0 concentration in brain tissue is about equal to the
cerebral venous blood concentration. Because
the method requires sampling of both arterial
and cerebral venous blood, it lends itself readily
to the simultaneous measurement of arteriovenous differences of substances involved in cerebral metabolism. This method and its modifications have provided most of our knowledge of
the rates of substrate utilization or product formation by brain in vivo.

REGULATION OF CEREBRAL
METABOLIC RATE

The brain consumes about one-fifth of
total body oxygen utilization
The brain is metabolically one of the most active
of all organs in the body. This consumption of
0 2 provides the energy required for its intense
physicochemical activity. The most reliable data
on cerebral metabolic rate have been obtained in
humans. Cerebral 0 2 consumption in normal,
conscious, young men is approximately 3.5
ml/100 g brain/min (Table 31-1); the rate is similar in young women. The rate of 0 2 consumption by an entire brain of average weight (1,400
g) is then about 49 ml 0 2 /min. The magnitude of
this rate can be appreciated more fully when it is
compared with the metabolic rate of the whole
body. An average man weighs 70 kg and con-

CBF= 100!\ V(1)tn[A(t)- V(t)] dt

where A(t) and V(t) are the arterial and cerebral
venous blood concentrations of N,O, respeclively, at any time t; V(T) is concentration of
N 20 in venous blood at the end of the period of
inhalation, that is, time T; X. is the partition coefficient for N 20 between brain tissue and blood; t
is variable time in minutes; T is total period of
inhalation ofN 2 0, usually 10 min or more; and
fl[A(t) - V(t)] dt is the integrated arteriovenous difference in N 2 0 concentrations over the
total period of inhalation.
The partition coefficient for N 20 is approximately 1 when equilibrium has been achieved
between blood and brain tissue; at least 10 min

CEREBRAL BLOOD FLOW AND
METABOLIC RATE IN A NORMAL YOUNG ADULT MAN•

Per 100 g
Function
Cerebral blood flow

of brain
tissue
57

Per whole
brain
(1,400g)

798

(mVmin)

Cerebral 0 2 consumption

3.5

49

5.5

77

(mVmin)

Cerebral glucose utilization
(mg/min)

a Based on data derived from the literature, in Sokoloff

[16).
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sumes about 250 ml 0 2 /min in the basal state.
Therefore, the brain, which represents only
about 2% of total body weight, accounts for 20%
of the resting total body 0 2 consumption. In
children, the brain takes up an even larger fraction, as much as 50% in the middle of the first
decade of life [15].
0 2 is utilized in the brain almost entirely for
the oxidation of carbohydrate [16]. The energy
equivalent of the total cerebral metabolic rate
is, therefore, approximately 20 W, or 0.25
kcal/min. If it is assumed that this energy is utilized mainly for the synthesis of high-energy
phosphate bonds, that the efficiency of the energy conservation is approximately 20% and that
the free energy of hydrolysis of the terminal
phosphate of ATP is approximately 7 kcal!mol,
then this energy expenditure can be estimated to
support the steady turnover of close to 7 mmol,
or approximately 4 X 1021 molecules, of ATP
per minute in the entire human brain. The brain
normally has no respite from this enormous energy demand. Cerebral 0 2 consumption continues unabated day and night. Even during sleep
there is only a relatively small decrease in cerebral metabolic rate; indeed, it may even be increased in rapid eye movement (REM) sleep (see
below).

The main energy-demanding functions
of the brain are those of ion flux related
to excitation and conduction
The brain does not do mechanical work, like that
of cardiac and skeletal muscle, or osmotic work,
as the kidney does in concentrating urine. It does
not have the complex energy-consuming
metabolic functions of the liver nor, despite the
synthesis of some hormones and neurotransmitters, is it noted for its biosynthetic activities.
Considerable emphasis has been placed on the
extent of macromolecular synthesis in the central nervous system, an interest stimulated by the
recognition that there are some proteins with
short half-lives in brain. However, these represent relatively small numbers of molecules, and
in fact, the average protein turnover and the rate
of protein synthesis in mature brain are slower
than in most other tissues, except perhaps muscle. Clearly, the functions of nervous tissues are
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mainly excitation and conduction, and these are
reflected in the unceasing electrical activity of
the brain. The electrical energy ultimately is derived from chemical processes, and it is likely
that most of the energy consumption of the
brain is used for active transport of ions to sustain and restore the membrane potentials discharged during the processes of excitation and
conduction (see Chaps. 5 and 6).
Not all of the 0 2 consumption of the brain
is used for energy metabolism. The brain contains a variety of oxidases and hydroxylases that
function in the synthesis and metabolism of a
number of neurotransmitters. For example, tyrosine hydroxylase is a mixed-function oxidase
that hydroxylates tyrosine to 3,4-dihydroxyphenylalanine (DOPA), and dopamine 13-hydroxylase hydroxylates dopamine to form norepinephrine. Similarly, tryptophan hydroxylase
hydroxylates tryptophan to form 5-hydroxytryptophan in the pathway of serotonin synthesis. The enzymes are oxygenases, which utilize
molecular 0 2 and incorporate it into the hydroxyl group of the hydroxylated products. 0 2
also is consumed in the metabolism of these
monoamine neurotransmitters, which are
deaminated oxidatively to their respective aldehydes by monoamine oxidases. All of these enzymes are present in brain, and the reactions catalyzed by them use 0 2 • However, the total
turnover rates of these neurotransmitters and
the sum total of the maximal velocities of all oxidases involved in their synthesis and degradation can account for only a very small, possibly
immeasurable, fraction of the total 0 2 consumption of brain.

Continuous cerebral circulation is
absolutely required to provide sufficient
oxygen
Not only does the brain utilize 0 2 at a very rapid
rate, but it is absolutely dependent on uninterrupted oxidative metabolism for maintenance of
its functional and structural integrity. There is a
large Pasteur effect in brain tissue, but even at its
maximal rate anaerobic glycolysis is unable to
provide sufficient energy. Since the 0 2 stored in
brain is extremely small compared with its rate
of utilization, the brain requires continuous re-
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plenishment of its 0 2 by the circulation. If cerebral blood flow is interrupted completely, consciousness is lost within less than 10 sec, or the
amount of time required to consume the 0 2
contained within the brain and its blood content. Loss of consciousness as a result of anoxemia, caused by anoxia or asphyxia, takes only a
little longer because of the additional 0 2 present
in the lungs and the still-circulating blood. The
average critical level of 0 2 tension in brain tissues, below which consciousness and the normal
EEG pattern are invariably lost, lies between 15
and 20 mm Hg. This seems to be so whether the
tissue anoxia is achieved by lowering the cerebral
blood flow or the arterial oxygen content. Cessation of cerebral blood flow is followed within a
few minutes by irreversible pathological changes
within the brain, readily demonstrated by microscopic anatomical techniques. In medical
crises, such as cardiac arrest, damage to the brain
occurs earliest and is most decisive in determining the degree of recovery.
Cerebral blood flow must be able to maintain the avaricious appetite of the brain for 0 2 •
The average rate of blood flow in the human
brain as a whole is approximately 57 ml/100 g
tissue/min (see Table 31-1). For a whole brain
this amounts to almost 800 ml/min, or approximately 15% of the total basal cardiac output.
This must be maintained within relatively narrow limits, for the brain cannot tolerate any major drop in its perfusion. A fall in cerebral blood
flow to half its normal rate is sufficient to cause
loss of consciousness in normal, healthy, young
men. There are, fortunately, numerous reflexes
and other physiological mechanisms to sustain
adequate le_;els of arterial blood pressure at the
head level, such as the baroreceptor reflexes, and
to maintain cerebral blood flow, even when arterial pressure falls in times of stress for example,
autoregulation. There are also mechanisms to
adjust cerebral blood flow to changes in cerebral
metabolic demand.
Regulation of cerebral blood flow is
achieved mainly by control of the tone or the degree of constriction, or dilation, of the cerebral
vessels. This in turn is controlled mainly by local
chemical factors, such as PaC02 , Pa02 , pH and
others still unrecognized. High PaC02, low Pa02

and low pH, which are products of metabolic activity, tend to dilate the blood vessels and increase cerebral blood flow; changes in the opposite direction constrict the vessels and decrease
blood flow [17]. Cerebral blood flow is regulated
through such mechanisms to maintain homeostasis of these chemical factors in the local tissue. The rates of production of these chemical
factors depend on the rates of energy
metabolism; therefore, cerebral blood flow is adjusted to the cerebral metabolic rate [ 17].

Local rates of cerebral blood flow and
metabolism can be measured by
autoradiography and are coupled to
local brain function
The rates of blood flow and metabolism presented in Table 31-1 and discussed above represent the average values in the brain as a whole.
The brain is not homogeneous, however; it is
composed of a variety of tissues and discrete
structures that often function independently or
even inversely with respect to one another.
There is little reason to expect that their perfusion and metabolic rates would be similar. Indeed, experiments clearly indicate that they are
not. Local cerebral blood flow in laboratory animals has been determined from the local tissue
concentrations, measured by a quantitative autoradiographic technique, and from the total
history of the arterial concentration of a freely
diffusible, chemically inert, radioactive tracer introduced into the circulation [18]. The results
reveal that blood-flow rates vary widely
throughout the brain, with average values in
gray matter approximately four to five times
those in white matter [18].
A method has been devised to measure
glucose consumption in discrete functional and
structural components of the brain in intact,
conscious laboratory animals [19]. This
method also employs quantitative autoradiography to measure local tissue concentrations
but utilizes 2-deoxy-o-[ 14 C]glucose as the
tracer. The local tissue accumulation of
[ 14 C]deoxyglucose as [ 14 C]deoxy-G6P in a
given interval of time is related to the amount
of glucose that has been phosphorylated by
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FIGURE 31-3. Theoretical basis of radioactive deoxyglucose method for measurement of local cerebral glucose utilization. A: Theoretical model. Ci represents the totai' 4C concentration in a single homogeneous tissue of the brain.
C~ and Cp represent the concentrations of [' 4C}deoxyglucose and glucose in the arterial plasma, respectively; C£ and
CE represent their respective concentrations in the tissue pools that serve as substrates for hexokinase. CM represents
the concentration of (14()deoxyglucose-6-phosphate in the tissue. k; k2 and k3 represent the rate constants for carrier-mediated transport of [ 14C)deoxyglucose from plasma to tissue, for carrier-mediated transport back from tissue
to plasma and for phosphorylation by hexokinase, respectively. k 1, k 2 and k3 are the equivalent rate constants for glucose. [ 14C]Deoxyglucose and glucose share and compete for the carrier that transports them both between plasma
and tissue and for hexokinase, which phosphorylates them to their respective hexose-6-phosphates. Dashed arrow
represents the possibility of glucose-6-phosphate hydrolysis by glucos.e-6-phosphatase activity, if any. UDPDG, UDPdeoxyglucose. (Figure continues on next page.}

hexokinase over the same interval, and the rate
of glucose consumption can be determined
from the [ 14 C] deoxy-G6P concentration by appropriate consideration of (i) the relative concentrations of [ 14C]deoxyglucose and glucose
in the plasma, (ii) their rate constants for transport between plasma and brain tissue and (iii)
the kinetic constants of hexokinase for de-

oxyglucose and glucose. The method is based
on a kinetic model of the biochemical behavior
of 2-deoxyglucose and glucose in brain. The
model (diagrammed in Fig. 31-3) has been analyzed mathematically to derive an operational
equation that presents the variables to be measured and the procedure to be followed to determine local cerebral glucose utilization.
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General equation for measurement of reaction rates with tracers:
Labeled Product Formed in Interval of Time, 0 to T
Rate of reaction=
[ Isotope effect
correction factor

J

[ Integrated specific activity
of precursor

J

Operational equation of [ 1.C]deoxyglucose method:

labeled Product formed in Interval of Time, 0 to T
Total ••c in tissue
at timeT
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remaining in tissue at time T

~
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FIGURE 31·3.

Correction for lag in tissue
equilibration with plasma

(Continued.) B: Functional anatomy of the operational equation of the radioactive deoxyglucose

method. Trepresents the time at the termination of the experimental period;>.. equals the ratio of the distribution space
of deoxyglucose in the tissue to that of glucose; ¢ equals the fraction of glucose that, once phosphorylated, continues down the glycolytic pathway; K~, V~ and Km, Vm represent the familiar Michaelis-Menten kinetic constants of hexokinase for deoxyglucose and glucose, respectively. Other symbols are the same as those defined in A. (From [19].)

To measure local glucose utilization, a pulse
of ("C]deoxyglucose is administered intravenously at time zero and timed arterial blood
samples are drawn for determination of the
plasma [ 14CJdeoxyglucose and glucose concentrations. At the end of the experimental period, usually about 45 min, the animal is decapitated, the
brain is removed and frozen and 20-f.1m-thick
brain sections are auto radiographed on X-ray film
along with calibrated ( 14C]methyl-methacrylate
standards. Local tissue concentrations of 14C are
determined by quantitative densitometric analysis
of the autoradiographs. From the time courses of
the arterial plasma (14C]deoxyglucose and glucose
concentrations and the final tissue 14C concentrations, determined by quantitative autoradiography, local glucose utilization can be calculated by
means of the operational equation for all components of the brain identifiable in the autoradiographs. The procedure is designed so that the autoradiographs reflect mainly the relative local

concentrations of ( 14C]deoxy-G6P. The autoradiographs, therefore, are pictorial representations
of the relative rates of glucose utilization in all of
the structural components of the brain.
Autoradiographs of the striate cortex in
monkey in various functional states are illustrated in Figure 31-4. This method has demonstrated that local cerebral consumption of glucose varies as widely as blood flow throughout
the brain (Table 31-2). Indeed, in normal animals, there is remarkably close correlation between local cerebral blood flow and glucose consumption (20]. Changes in functional activity
produced by physiological stimulation, anesthesia or deafferentation result in corresponding
changes in blood flow and glucose consumption
(21] in the structures involved in the functional
change. The ( 14C]deoxyglucose method for the
measurement of local glucose utilization has
been used to map the functional visual pathways
and to identify the locus of the visual cortical
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FIGURE 31-4. Autoradiograms of
coronal bra in sections from rhesus
monkeys at the level of the striate
cortex. A: Animal with normal binocular vision. Note the laminar distribution of the density; the dark band
corresponds to layer IV. B: Animal
with bilateral visual deprivation. Note
the almost uniform and reduced relative density, especially the virtual disappearance of the dark band corresponding to layer IV. C: Animal with
right eye occluded. The half-brain on
the left represents the left hemisphere contralateral to the occluded
eye. Note the alternate dark and light
striations, each approximately 0.3 to
0.4 mm in width, representing the
ocular dominance columns. These
columns are most apparent in the
dark lamina corresponding to layer IV
but extend through the entire thickness of the cortex. Arrows point to
regions of bilateral asymmetry,
where the ocular dominance
columns are absent. These are presumably areas that normally have
only monocu lar input. The one on
the left, contralateral to the occluded eye, has a continuous dark
lamina corresponding to layer IV that
is completely absent on the side ipsilateral to the occluded eye. These regions are believed to be the loci of
t he cortical representations of the
blind spots. (From [21).)
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REPRESENTATIVE VALUES•
FOR LOCAL CEREBRAL GLUCOSE UTILIZATION IN THE
NORMAL CONSCIOUS ALBINO

Monkeyo:
Gray matter
Visual cortex
Auditory cortex
Parietal cortex
Sensorimotor cortex
Thalamus: lateral nucleus
Thalamus: ventral nucleus
Medial geniculate body
Lateral geniculate body
Hypothalamus

Mammillary body
Hippocampus

107 :!:: 6

162 :!: 5
112:!: 5

120 ± 5

116
109
131
96
54
121

"' 5
"' 5
"' 5
"' 5
±2
"'5

79 ± 3

Amygdala

52 "' 2

Caudate putamen
Nucleus accumbens
Globus pallidus
Substantia nigra
Vestibular nucleus
Cochlear nucleus
Superior olivary nucleus

Inferior colliculus
Superior colliculus

39 ±
25 ±
57::!:
39 ±

1
1
3
2

25 "' 2
52 "' 3

82 "' 3
58 "' 2

36 ± 2
26 ± 2

58 :!:: 3

29 :!:: 2

128 "' 5

66"' 3
51 ± 3

113 ± 7
133 ::!:: 7
95 :!:: 5
62 ::!::: 3
57::!:: 2

White matter
Corpus callosum
Internal capsule
Cerebellar white matter

54 "' 2
43 "' 2
65 "' 3

110 ± 4

197 :!:: 10

Pontine gray matter
Cerebellar cortex
Cerebellar nuclei

59 :!: 2
79 :!: 4
47 :!: 4
44 ± 3

63 :!:: 4

103 ::!:: 6
55 :!:: 4
28 ::!:: 1

31 "' 2

100 ± 4

45 ± 2

40 ± 2
33 ± 2
37 ± 2

11 ± 1
13 ± 1
12 ± 1

Weighted average for whole brain
68 ± 3

36 ± 1

Values are the means plus or minus standard errors
from measurements made in ten rats or seven monkeys.
b From Sokoloff and co workers [19] .
c From Kennedy and co workers [22].

a

4

4

representation of the retinal "blind spot" in the
brain of rhesus monkey [21] (Fig. 31-4). These
results establish that local energy metabolism in
the brain is coupled to local functional activity
and confirm the long-held belief that local cerebral blood flow is adjusted to metabolic demand
in local tissue. The method has been applied to
humans by use of2-[ 18 F]-fluoro-2-deoxy-o-glucose and positron emission tomography (PET),
with similar results (see Chap. 54).

Metabolism

SUBSTRATES OF CEREBRAL
METABOLISM
Normally, the substrates are glucose and
oxygen and the products are carbon
dioxide and water

In contrast to most other tissues, which exhibit
considerable flexibility with respect to the nature
of the foodstuffs extracted and consumed from
the blood, the normal brain is restricted almost
exclusively to glucose as the substrate for its energy metabolism. Despite long and intensive efforts, the only incontrovertible and consistently
positive arteriovenous differences demonstrated
for the human brain under normal conditions
have been for glucose and oxygen [16]. Negative
arteriovenous differences, significantly different
from zero, have been found consistently only for
C0 2 , although water, which has never been measured, also is produced. Pyruvate and lactate
production have been observed occasionally,
certainly in aged subjects with cerebral vascular
insufficiency but also irregularly in subjects with
normal oxygenation of the brain.
In the normal in vivo state, glucose is the
only significant substrate for energy metabolism
in the brain. Under normal circumstances, no
other potential energy-yielding substance has
been found to be extracted from the blood in
more than trivial amounts. The stoichiometry of
glucose utilization and 0 2 consumption is summarized in Table 31-3. The normal, conscious
human brain consumes oxygen at a rate of 156
fLmol/100 g tissue/min. C0 2 production is the
same, leading to a respiratory quotient (RQ) of
1.0, further evidence that carbohydrate is the ultimate substrate for oxidative metabolism. 0 2
consumption and C02 production are equivalent
to a rate of glucose utilization of 26 fLmol/100 g
tissue/min, assuming 6 J.Lmol of 0 2 consumed
and of C0 2 produced for each micromole of glucose completely oxidized to C0 2 and H 2 0. The
actual glucose utilization measured is, however,
31 fLmol/100 glmin, which indicates that glucose
consumption not only is sufficient to account for
total 0 2 consumption but is in excess by 5
fLmol/100 glmin. For complete oxidation of glucose, the theoretical ratio of 0 2: glucose utilization is 6.0; the excess glucose utilization is re-
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RELATIONSHIP BETWEEN
CEREBRAL OXYGEN CONSUMPTION AND GLUCOSE
UTILIZATION IN A NORMAL
YOUNG ADULT MAN
Valuea

0 2 consumption (j.LmoV1 00 g brain
tissue/min)

156

Glucose utilization {j.LmoV1 00 g
brain tissue/min)
0 2 :glucose ratio (moVmol)

31

Glucose equivalent of 0 2 consumption
{1-Lmol glucose/1 00 g brain tissue/min)
C0 2 production (j.LmoV1 00 g brain
tissue/min)

26'

Cerebral respiratory quotient (RQ)

156

0.97

From Sokoloff [16[.
a Values are the median of values reported in the litera-

ture.
b Calculated on the basis of 6 mol of 0 2 required for
complete oxidation of 1 mol of glucose.

sponsible for a measured ratio of only 5.5 f.Lmol
0 2/f.Lmol glucose. The fate of the excess glucose is
unknown, but it probably is distributed in part in
lactate, pyruvate and other intermediates of carbohydrate metabolism, each released from the
brain into the blood in insufficient amounts to be
detectable as significant arteriovenous differences. Some of the glucose must be utilized not
for the production of energy but for synthesis of
the chemical constituents of brain.
Some oxygen is used for oxidation of substances not derived from glucose, for example, in
the synthesis and metabolic degradation of
monoamine neurotransmitters, as mentioned
above. The amount of 0 2 used for these processes is, however, extremely small and is undetectable in the presence of the enormous 0 2 consumption used for carbohydrate oxidation.
The combination of a cerebral RQ of unity,
an almost stoichiometric relationship between
0 2 uptake and glucose consumption and the absence of any significant arteriovenous difference
for any other energy-rich substrate is strong evidence that the brain normally derives its energy
from the oxidation of glucose. Thus, cerebral
metabolism is unique because no other tissue,
except for testis [23], relies only on carbohydrate
for energy.
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This does not imply that the pathways of
glucose metabolism in the brain lead, like combustion, directly and exclusively to production
of C0 2 and H 2 0. Various chemical and energy
transformations occur between uptake of the
primary substrates glucose and 0 2 and liberation
of the end products C0 2 and H 2 0. Compounds
derived from glucose or produced through the
energy made available from glucose catabolism
are intermediates in the process. Glucose carbon
is incorporated, for example, into amino acids,
protein, lipids and glycogen. These are turned
over and act as intermediates in the overall pathway from glucose to C0 2 and H 2 0. There is clear
evidence from studies with [ 14 C]glucose that not
all of the glucose is oxidized directly and that at
any given moment some of the C0 2 being produced is derived from sources other than glucose
that enter the brain at the same moment or just
prior to that moment. That 0 2 and glucose consumption and C0 2 production are essentially in
stoichiometric balance and that no other energyladen substrate is taken from the blood means,
however, that the net energy made available to
the brain ultimately must be derived from the
oxidation of glucose. It should be noted that this
is the situation in the normal state; as discussed
later, other substrates may be used in special circumstances or in abnormal states.

In brain, glucose utilization is obligatory
The brain normally derives almost all of its energy from the aerobic oxidation of glucose, but
this does not distinguish between preferential
and obligatory utilization of glucose. Most tissues are largely facultative in their choice of substrates and can use them interchangeably more
or less in proportion to their availability. This
does not appear to be so in the brain. Except in
some unusual and very special circumstances,
only the aerobic utilization of glucose is capable
of providing the brain with sufficient energy to
maintain normal function and structure. The
brain appears to have almost no flexibility in its
choice of substrates in vivo. This conclusion is
derived from the following evidence.
Glucose deprivation is followed rapidly by aberrations of cerebral function. Hypoglycemia, pro-
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duced by excessive insulin or occurring spontaneously in hepatic insufficiency, is associated
with changes in mental state ranging from mild,
subjective sensory disturbances to coma, the
severity depending on both the degree and the
duration of the hypoglycemia. The behavioral
effects are paralleled by abnormalities in EEG
patterns and cerebral metabolic rate. The EEG
pattern exhibits increased prominence of slow,
high-voltage &rhythms, and the rate of cerebral
oxygen consumption falls. In studies of the effects of insulin hypoglycemia in humans [24], it
was observed that when arterial glucose fell from
a normal concentration of70 to 100 mg/100 ml
to an average of 19 mg/100 ml, subjects became
confused and cerebral oxygen consumption fell
to 2.6 ml/100 glmin, or 79% of normal. When
arterial glucose fell to 8 mg/100 ml, a deep coma
ensued and cerebral 0 2 consumption decreased
even further to 1.9 ml/100 glmin (Table 31-4).
These changes are not caused by insufficient cerebral blood flow, which actually increases slightly during coma. In the depths of
coma, when the blood glucose content is very
low, there is almost no measurable cerebral uptake of glucose from the blood. Cerebral 0 2 consumption, although reduced, is still far from
negligible; and there is no longer any stoichiometric relationship between glucose and 0 2 uptakes by the brain, evidence that the 0 2 is utilized
for the oxidation of other substances. The cerebral RQ remains approximately l, however, indicating that these other substrates are still car-

bohydrate, presumably derived from the endogenous carbohydrate stores of the brain. The
effects are clearly the result of hypoglycemia and
not of insulin in the brain. In all cases, the behavioral, functional and cerebral metabolic abnormalities associated with insulin hypoglycemia are reversed rapidly and completely by
the administration of glucose. The severity of the
effects is correlated with the degree of h ypoglycemia and not the insulin dosage, and the effects of insulin can be prevented completely by
the simultaneous administration of glucose with
the insulin.
Similar effects are observed in hypoglycemia produced by other means, such as hepatectomy. Inhibition of glucose utilization at the
phosphohexose isomerase step with pharmacological doses of2-deoxyglucose also produces all
of the cerebral effects of hypoglycemia despite an
associated elevation in blood glucose content.
In hypoglycemia, substrates other than glucose
may be utilized. The hypoglycemic state provides convenient test conditions to determine
whether a substance is capable of substituting for
glucose as a substrate of cerebral energy
metabolism. If it can, its administration during
hypoglycemic shock should restore consciousness and normal cerebral electrical activity without raising the blood glucose concentration. Numerous potential substrates have been tested in
humans and animals. Very few can restore normal cerebral function in hypoglycemia, and of

EFFECTS OF INSULIN HYPOGLYCEMIA ON CEREBRAL CIRCULATION AND
METABOLISM IN HUMANS•

Insulin-induced
Control
Arterial blood
Glucose concentration (mg%)
0 2 content (vol%)
Mean blood pressure (mm Hg)

74
17.4
94

Cerebral circulation
Blood flow (mV1 00 g/min)
0 2 consumption (mV1 00 g/min)
Glucose consumption (mg/1 00 g/min)
Respiratory quotient

58
3.4
4.4
0.95

" from Kety et al. [24}.

hypoglycemia
without coma

Insulin-induced
hypoglycemic coma

19
17.9

16.6

86

93

61

63
1.9

2.6
2.3
1.10

0.8

0.92
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these all but one appear to operate through a variety of mechanisms to raise the blood glucose
concentration rather than by serving directly as a
substrate (Table 31-5).
Mannose appears to be the only substance
that can be utilized by the brain directly and
rapidly enough to restore or maintain normal
function in the absence of glucose [25]. It traverses the BBB and is converted to mannose-6phosphate. This reaction is catalyzed by hexokinase as effectively as the phosphorylation of
glucose. The mannose-6-phosphate is then converted to fructose-6-phosphate by phosphomannose isomerase, which is active in brain tissue. Through these reactions mannose can enter
directly into the glycolytic pathway and replace
glucose.
Maltose also is effective occasionally in
restoring normal behavior and EEG activity in
hypoglycemia but only by raising the blood glucose concentration through its conversion to
glucose by maltase activity in blood and other
tissues [16]. Epinephrine is effective at producing arousal from insulin coma, but this is
achieved through its well-known stimulation of
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glycogenolysis and the elevation of blood glucose concentration. Glutamate, arginine,
glycine, GABA and succinate also act through
adrenergic effects that raise glucose concentrations of the blood [16].
It should be noted, however, that failure to
restore normal cerebral function in hypoglycemia is not synonymous with an inability of
the brain to utilize the substance. Many of the
substances that have been tested and found ineffective are compounds normally formed and utilized within the brain and are normal intermediates in its intermediary metabolism. Lactate;
pyruvate; fructose-1,6-bisphosphate; acetate; 13hydrox:ybutyrate; and acetoacetate can be utilized by brain slices, homogenates or cell-free
fractions; and the enzymes for their metabolism
are present in brain. Enzymes for the
metabolism of glycerol or ethanol, for example,
may not be present in sufficient amounts. For
other substrates, for example, n-13-hydroxybutyrate and acetoacetate, the enzymes are adequate but the substrate is not available to the
brain because of inadequate blood levels or restricted transport through the BBB.

EFFECTIVENESS OF VARIOUS SUBSTANCES IN PREVENTING OR REVERSING
THE EFFECTS OF HYPOGLYCEMIA OR GLUCOSE DEPRIVATION ON CEREBRAL
FUNCTION AND METABOLISM•
Substance
Epinephrine
Maltose

Partially or occasionally
effective

Ineffective

Man nose
Glutamate
Arginine
Glycine
p-Aminobenzoate
Succinate
Glycerol
Ethanol
lactate

Glyceraldehyde
Hexose diphosphates
Fumarate
Acetate
[3-Hydroxybutyrate
Galactose
Lactose
Insulin
aSummarized from the literature, in Sokoloff [ 16]

Comments
Raises blood glucose concentration
Converted to glucose and raises blood glucose
concentration
Directly metabolized and enters glycolytic pathway
Occasionally effective by raising blood glucose
concentration

Some of these substances can be metabolized
to various extents by brain tissue and conceivably
could be effective if it were not for the
blood-brain barrier
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Nevertheless, nervous system function in
the intact animal depends on substrates supplied
by the blood, and no satisfactory, normal, endogenous substitute for glucose has been found.
Glucose, therefore, must be considered essential
for normal physiological behavior of the central
nervous system.

The brain utilizes ketones in states of
ketosis
In special circumstances, the brain may fulfill its
nutritional needs partly, although not completely, with substrates other than glucose. Normally, there are no significant cerebral arteriovenous differences for o-13-hydroxybutyrate
and acetoacetate, which are "ketone bodies"
formed in the course of the catabolism of fatty
acids by liver. Owen and coworkers [26] observed, however, that when human patients
were treated for severe obesity by complete fasting for several weeks, there was considerable uptake of both substances by the brain. If one assumed that the substances were oxidized
completely, their rates of utilization would have
accounted for more than 50% of the total cerebral oxygen consumption, more than that accounted for by the glucose uptake. o-13-hydroxybutyrate uptake was several times greater than
that of acetoacetate, a reflection of its higher
concentration in the blood. The enzymes responsible for their metabolism, o-13-hydroxybutyrate dehydrogenase, acetoacetate-succinylCoA transferase and acetoacetyl-CoA-thiolase,
are present in brain tissue in sufficient amounts
to convert them into acyl-CoA and to feed them
into the tricarboxylic acid cycle at a sufficient
rate to satisfy the metabolic demands of the
brain [27].
Under normal circumstances, that is, ample glucose and few ketone bodies in the blood,
the brain apparently does not oxidize ketones
in any significant amounts. In prolonged starvation, the carbohydrate stores of the body are
exhausted and the rate of gluconeogenesis is insufficient to provide glucose fast enough to
meet the requirements of the brain; blood ketone concentrations rise as a result of the rapid
fat catabolism. The brain then apparently turns
to the ketone bodies as the source of its energy
supply.

Metabolism

Cerebral utilization of ketone bodies appears to follow passively their concentrations in
arterial blood [27]. In normal adults, ketone
concentrations are very low in blood and cerebral utilization of ketones is negligible. In ketotic states resulting from starvation; fat-feeding or ketogenic diets; diabetes; or any other
condition that accelerates the mobilization and
catabolism of fat, cerebral utilization of ketones
is increased more or less in direct proportion to
the degree of ketosis [27]. Significant utilization of ketone bodies by the brain is, however,
normal in the neonatal period. The newborn
infant tends to be hypoglycemic but becomes
ketotic when it begins to nurse because of the
high fat content of the mother's milk. When
weaned onto the normal, relatively high-carbohydrate diet, the ketosis and cerebral ketone
utilization disappear. Studies have been carried
out mainly in the infant rat, but there is evidence that the situation is similar in the human
infant.
The first two enzymes in the pathway of ketone utilization are o-13-hydroxybutyrate dehydrogenase and acetoacetyl-succinyl-CoA transferase. These exhibit a postnatal pattern of
development that is well adapted to the nutritional demands of the brain. At birth, the activity of these enzymes in the brain is low; activity
rises rapidly with the ketosis that develops with
the onset of suckling, reaches its peak just before
weaning and then gradually declines after weaning to normal adult rates of approximately onethird to one-fourth the maximal rates attained
[27,28].
It should be noted that o-13-hydroxybutyrate is incapable of maintaining or restoring
normal cerebral function in the absence of glucose in the blood. This suggests that, although it
can partially replace glucose, it cannot fully satisfy the cerebral energy needs in the absence of
some glucose consumption. One explanation
may be that the first product ofo-13-hydroxybutyrate oxidation, acetoacetate, is metabolized
further by its displacement of the succinyl moiety of succinyl-CoA to form acetoacetyl-GoA. A
certain rate of glucose utilization may be essential to drive the tricarboxylic cycle, to provide
enough succinyl-CoA to permit the further oxidation of acetoacetate and, hence, to pull along
the oxidation ofo-13-hydroxybutyrate.

Chapter 31
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AGE AND DEVELOPMENT
INFLUENCE CEREBRAL ENERGY
METABOLISM

Metabolic rate increases during early
development
The energy metabolism of the brain and the blood
flow that sustains it vary considerably from birth
to old age. Data on the cerebral metabolic rate obtained directly in vivo are lacking for the early postnatal period, but the results of in vitro measurements in animal brain preparations and inferences
drawn from cerebral blood flow measurements in
intact animals [29] suggest that cerebral oxygen
consumption is low at birth, rises rapidly during
the period of cerebral growth and development
and reaches a maximal level at about the time maturation is completed. This rise is consistent with
the progressive increase in the levels of a number
of enzymes of oxidative metabolism in the brain.
The rate ofblood flow in different structures of the
brain reaches peak levels at different times, depending on the maturation rate of the particular
structure. In structures that consist predominantly
of white matter, the peaks coincide roughly with
maximal rates of myelination. From these peaks,
blood flow and, probably, cerebral metabolic rate
decline to the levels characteristic of adulthood.

Metabolic rate declines and plateaus
after maturation
Reliable quantitative data on the changes in cerebral circulation and metabolism in humans

from the middle of the first decade of life to old
age are summarized in Table 31-6. By 6 years of
age, cerebral blood flow and oxygen consumption already have attained high rates, and they
decline thereafter to the rates of normal young
adulthood [15]. Cerebral oxygen consumption
of5.2 ml/100 g brain tissue/ min in a 5- to 6-yearold child corresponds to total oxygen consumption by the brain of approximately 60 ml!min, or
more than 50% of the total body basal oxygen
consumption, a proportion markedly greater
than that occurring in adulthood. The reasons
for the extraordinarily high cerebral metabolic
rates in children are unknown, but presumably
they reflect the extra energy requirements for the
biosynthetic processes associated with growth
and development.

Tissue pathology, but not aging,
produces secondary changes in
metabolic rate
Whole-brain cerebral blood flow and oxygen
consumption normally remain essentially unchanged between young adulthood and old age.
In a population of normal elderly men in their
eighth decade of life, who were selected carefully
for good health and freedom from all disease including vascular disease, both blood flow and
oxygen consumption were not significantly different from rates of normal young men SO years
younger (see Table 31-6) [30]. In a comparable
group of elderly subjects, who differed only by
the presence of objective evidence of minimal arteriosclerosis, cerebral blood flow was signifi-

AGE AND SENILITY•

Cerebral
life period and condition
Childhood
Normal young adulthood
Aged
Normal elderly

Elderly with minimal arteriosclerosis
Elderly with senile psychosis

Age
(years)
fib

21

blood flow
(ml/100 g/min)

Cerebral 0 2
consumption

Cerebral venous
0 2 tension

(ml/100 g/min)

(mmHg)

1Q6b

5.2b

62

3.5

38

3.3
3.2
2.7b.c

36
33b,c

71 '

58

73b

48b

72'

48b,c

•From Kennedy and Sokoloff [151 and Sokoloff [301.
bStatistically significant difference from normal young adult (p < 0.05).
cStatistically significant difference from normal elderly subjects (p < 0.05).

33b.c
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cantly lower. It had reached a point at which the
oxygen tension of the cerebral venous blood declined, an indication of relative cerebral hypoxia.
However, normal cerebral oxygen consumption
was maintained through extraction of larger
than normal proportions of the arterial blood
oxygen. In senile, psychotic patients with arteriosclerosis, cerebral blood flow was no lower
but cerebral oxygen consumption had declined.
These data suggest that aging per se need not
lower cerebral oxygen consumption and blood
flow but that, when blood flow is reduced, it is
probably secondary to vascular disease, which
produces cerebral vascular insufficiency and
chronic relative hypoxia in the brain, or to another tissue pathology that decreases function,
such as dementia (see Chap. 46). Because arteriosclerosis and Alzheimer's disease are so prevalent in the aged population, most individuals
probably follow the latter pattern. However, agerelated changes in local regulation are possible
and are the subject of research (see Chap. 30).

Metabolism

function [21]. For example, diminished visual or
auditory input depresses glucose utilization in
all components of the central visual or auditory
pathways, respectively (Fig. 31-4). Focal seizures
increase glucose utilization in discrete components of the motor pathways, such as the motor
cortex and the basal ganglia (Fig. 31-5).
Convulsive activity, induced or spontaneous, often has been employed as a method of
increasing electrical activity of the brain (see
Chap. 37). Davies and Remand [13] used the
oxygen electrode technique in the cerebral cortex of cat and found increases in oxygen consumption during electrically induced or druginduced convulsions. Because the increased
oxygen consumption either coincided with or
followed the onset of convulsions, it was concluded that the elevation in metabolic rate was
the consequence of the increased functional activity produced by the convulsive state (see
Chaps. 37 and 54).

Metabolic rate and nerve conduction are
related directly

CEREBRAL METABOLIC RATE IN
VARIOUS PHYSIOLOGICAL STATES
Cerebral metabolic rate is determined
locally by functional activity in discrete
regions
In organs such as heart or skeletal muscle that
perform mechanical work, increased functional
activity clearly is associated with increased
metabolic rate. In nervous tissues outside the
central nervous system, electrical activity is an
almost quantitative indicator of the degree of
functional activity; and in structures such as
sympathetic ganglia and postganglionic axons,
increased electrical activity produced by electrical stimulation definitely is associated with increased utilization of oxygen. Within the central
nervous system, local energy metabolism also is
correlated closely with the level of local functional activity. Studies using the [ 14 C]deoxyglucose method have demonstrated pronounced
changes in glucose utilization associated withaltered functional activity in discrete regions of the
central nervous system specifically related to that

The [ 14C] deoxyglucose method has defined the
nature and mechanisms of the relationship between energy metabolism and functional activity
in nervous tissues. Studies in the superior cervical ganglion of the rat have shown almost a direct relationship between glucose utilization in
the ganglion and spike frequency in the afferent
fibers from the cervical sympathetic trunk [31].
A spike results from the passage of a finite current ofNa + into the cell and ofK+ out of the cell,
ion currents that degrade the ionic gradients responsible for the resting membrane potential.
Such degradation can be expected to stimulate
Na,K-ATPase activity to restore the ionic gradients to normal, and such ATPase activity in tum
would stimulate energy metabolism. Indeed,
Mata et al. [32] have found that, in the posterior
pituitary in vitro, stimulation of glucose utilization due to either electrical stimulation or opening of Na + channels in the excitable membrane
by veratridine is blocked by ouabain, a specific
inhibitor ofNa,K-ATPase activity (see Chap. 5).
Most, if not all, of the stimulated energy
metabolism associated with increased functional
activity is confined to the axonal terminals

FIGURE 31-5. Local glucose utiliza~
tion during penicillin~induced focal
seizures. Penicillin was applied to the
hand and face area of the left motor
cortex of a rhesus monkey. The left side
of the brain is on the left in each of the
autoradiograms in the figure. Numbers
are rates of local cerebral glucose utilization in micromoles per 100 g tissue
per minute. Note the following: upper
left motor cortex in region of penicillin
application and corresponding region
of contralateral motor cortex; lower
left ipsilateral and contralateral motor
cortical regions remote from area of
penicillin applications; upper right, ipsilateral and contralateral putamen and
globus pallidus; lower right, ipsilateral
and contralateral thalamic nuclei and
substant ia nigra. (From [21 }.)
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FIGURE 31·6. Effects of electrical stimulation of sciatic nerve on glucose utilization in the terminal zones in the dorsal horn of the spinal cord and in the cell bodies in the dorsal root ganglion . (From [331.)

rather than to the cell bodies in a functionally activated pathway (Fig. 31-6) [33]. Astrocytes also
contribute to the increased metabolism [34].

It is difficult to define metabolic
equivalents of consciousness, mental
work and sleep
Mental work. Convincing correlations between
cerebral metabolic rate and mental activity have
been obtained in humans in a variety of pathological states of altered consciousness [35]. Regardless of the cause of the disorder, graded reductions in cerebral oxygen consumption are
accompanied by parallel graded reductions in
the degree of mental alertness, all the way to profound coma (Table 31-7). It is difficult to define
or even to conceive of the physical equivalent of
mental work. A common view equates concentrated mental effort with mental work, and it is

fashionable to attribute a high demand for mental effort to the process of problem solving in
mathematics. Nevertheless, there appears to be
no increased energy utilization by the brain during such processes. From resting levels, total
cerebral blood flow and oxygen consumption remain unchanged during the exertion of the
mental effort required to solve complex arithmetical problems [35]. It may be that the assumptions that relate mathematical reasoning to
mental work are erroneous, but it seems more
likely that the areas that participate in the processes of such reasoning represent too small a
fraction of the brain for changes in their ftmctional and metabolic activities to be reflected in
the energy metabolism of the brain as a whole.
Sleep. Physiological sleep is a naturally occurring, periodic, reversible state of unconsciousness; and the EEG pattern in deep, slow-wave
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RELATIONSHIP BETWEEN
LEVEL OF CONSCIOUSNESS

Cerebral
blood flow
(ml/100
g/min)

Cerebral 0 2
consumption
(ml/100
g/min)

Mentally alert
Normal young men

54

3.3

Mentally confused
Brain tumor
Diabetic acidosis
Insulin
hypoglycemia
Cerebral
arteriosclerosis

48

2.8

Comatose
Brain tumor
Diabetic coma
Insulin coma
Anesthesia

57

Level of
consciousness
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2.0

• From Sokoloff [35].

sleep is characterized by high-voltage, slow
rhythms very similar to those often seen in
pathological comatose states. As found in the
pathological comatose states, cerebral glucose
metabolism is depressed more or less uniformly
throughout the brain of rhesus monkeys in
stages 2 to 4 of normal sleep studied by the
[ 14 C]deoxyglucose method [36]. There are no
comparable data available for the state of paradoxical sleep, also termed REM sleep, or for normal sleep in humans. During the stages of sleep
as studied by PET scanning in humans, regional
blood flow measurements suggest selective deactivation in certain regions of association cortex
during slow-wave sleep and selective activation
in other regions during REM sleep [37]. Regional metabolic measurements show activation
in the same regions in association with rapid eye
movements during REM sleep as with saccadic
eye movements during wakefulness [38].

CEREBRAL ENERGY METABOLISM
IN PATHOLOGICAL STATES
The cerebral metabolic rate of the brain as a
whole is normally fairly stable and varies over a

relatively narrow range under physiological conditions. There are, however, a number of pathological states of the nervous system and other organs that affect the functions of the brain either
directly or indirectly, and some of these have
profound effects on cerebral metabolism.

Psychiatric disorders may produce
effects related to anxiety
In general, disorders that alter the quality of
mentation but not the level of consciousness
(described in Chaps. 51 and 52), such as the
functional neuroses, psychoses and psychotomimetic states, have no apparent effect on
the average blood flow and oxygen consumption
of the brain as a whole. Thus, no gross changes in
either function are observed in schizophrenia
[35] or LSD intoxication (Table 31-8) [35].
There is still uncertainty about the effects of anxiety, mainly because of the difficulties in evaluating quantitatively the intensity. It is generally
believed that ordinary degrees of anxiety,
or "nervousness," do not affect the cerebral
metabolic rate but that severe anxiety, or
"panic," may increase cerebral oxygen consumption [35]. This may be related to the level
of epinephrine circulating in the blood. Small
doses of epinephrine that raise heart rate and
cause some anxiety do not alter cerebral blood
flow and metabolism, but large doses that are
sufficient to raise the arterial blood pressure
cause significant increases in both.

CEREBRAL BLOOD FLOW AND
METABOLIC RATE IN
SCHIZOPHRENIA AND IN
NORMAL YOUNG MEN DURING LSD-INDUCED
PSYCHOTOMIMETIC STATE•

Condition

Cerebral
blood blow
(ml/100 g/min)

Cerebral 0 2
consumption
(ml/100 g/min)

Normal

67

3.9

LSD intoxication

68

3 .9

Schizophrenia

72

4.0

• From

Sokoloff [35].
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Coma and systemic metabolic diseases
depress brain metabolism
Coma is correlated with depression of cerebral
oxygen consumption; progressive reductions in
the level of consciousness are paralleled by corresponding graded decreases in cerebral metabolic
rate (Table 31-7). There are almost innumerable
derangements that can lead to depression of consciousness. Table 31-9 includes only a few typical
examples that have been studied by the same
methods and by the same or related groups of investigators. Metabolic encephalopathy is discussed in detail in Chapter 38.
Inadequate cerebral nutrient supply leads
to decreases in the level of consciousness, ranging from confusional states to coma. The nutrition of the brain can be limited by lowering the
oxygen or glucose concentrations of arterial
blood, as in anoxia or hypoglycemia, or by impairment of their distribution to the brain
through lowering cerebral blood flow, as in brain
tumors. Consciousness is then depressed, presumably because of inadequate supplies of substrate to support the energy metabolism necessary to sustain function of brain.

Metabolism

In a number of conditions, the causes of depression of both consciousness and the cerebral
metabolic rate are unknown and must, by exclusion, be attributed to intracellular defects in the
brain. Anesthesia is one example. Cerebral oxygen
consumption always is reduced in the anesthetized state regardless of the anesthetic agent
used, whereas blood flow may or may not be decreased and may even be increased. This reduction is the result of decreased energy demand and
not insufficient nutrient supply or a block of intracellular energy metabolism. There is evidence
that general anesthetics interfere with the balance
of excitatory and inhibitory synaptic transmission, particularly by an agonist action at GABAergic inhibitory synapses, thus reducing neuronal
interaction, functional activity and, consequently,
metabolic demands (see Chap. 16).
Several metabolic diseases with broad systemic manifestations also are associated with disturbances of cerebral function. Diabetes mellitus,
when allowed to progress to states of acidosis and
ketosis, leads to mental .c onfusion and, ultimately,
deep coma, with parallel proportionate decreases
in cerebral oxygen consumption (see Table 31-9)
[39]. The abnormalities usually are reversed com-

CEREBRAL BLOOD FLOW AND METABOLIC RATE IN HUMANS WITH VARIOUS
DISORDERS AFFECTING MENTAL STATE•
Condition

Normal
Increased intracranial pressure
(brain tumor)
Insulin hypoglycemia
Arterial glucose level
74 mg/100 ml
19 mg/100 ml
8 mg/100 ml

Thiopental anesthesia
Convulsive state
Before convulsion
After convulsion
Diabetes
Acidosis
Coma
Hepatic insufficiency
a

Cerebral blood flow
(ml/100 g/min)

Cerebral 0 2 consumption
(ml/100 g/min)

Alert
Coma

54
34b

3.3
2.5b

Alert

58
61
63

3.4

Confused
Coma
Coma

60b

2.6'>
1.9b
2.1b

Alert

Confused

58
37b

3.7
3.1b

Confused
Coma

45b
65b

2.7b
1.7b

Coma

33b

1.7b

Mental state

All studies listed were carried out by Kety and/or his associates, employing the same methods. For references, see

Kennedy and Sokoloff [15] and Sokoloff [35].
b

Denotes statistically significant difference from normal level (p < 0.05).
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pletely by adequate insulin therapy. The cause of
the coma or depressed cerebral metabolic rate is
not known. Deficiency of cerebral nutrition cannot be implicated because the blood glucose concentration is elevated and cerebral blood flow and
oxygen supply are more than adequate. Neither is
insulin deficiency, presumably the basis of the systemic manifestations of the disease, a likely cause
of the cerebral abnormalities since no absolute requirement of insulin for cerebral glucose utilization or metabolism has been demonstrated. Ketosis may be severe in this disease, and there is
evidence that a rise in the blood concentration of
at least one of the ketone bodies, acetoacetate, can
cause coma in animals. In studies of human diabetic acidosis and coma, a significant correlation
between the depression of cerebral metabolic rate
and the degree of ketosis has been observed, but
there is an equally good correlation with the degree of acidosis [39]. Hyperosmolarity itself may
cause coma. Ketosis, acidosis, hyperosmolarity or
a combination may be responsible for the disturbances in cerebral function and metabolism.
Coma occasionally is associated with severe
impairment of liver function, or hepatic insufficiency (see Chap. 38). In human patients in hepatic coma, cerebral metabolic rate is depressed
markedly (see Table 31-9). Cerebral blood flow
also is depressed moderately but not sufficiently
to lead to limiting supplies of glucose and oxygen.
Blood ammonia usually is elevated in hepatic
coma, and significant cerebral uptake of ammonia from the blood is observed. Ammonia toxicity, therefore, has been suspected as the basis for
cerebral dysfunction in hepatic coma. Because
ammonia can, through glutamic dehydrogenase
activity, convert o:-KG to glutamate by reductive
amination, it has been suggested that ammonia
might thereby deplete o:-KG and, thus, slow the
Krebs cycle (see Chaps. 15 and 38). The correlation between the degree of coma and blood ammonia is far from convincing, however, and coma
has been observed in the absence of an increase in
blood ammonia concentration. Although ammonia may be involved in the mechanism of hepatic
coma, the mechanism remains unclear, and other
causal factors probably are involved.
Depression of mental functions and of the
cerebral metabolic rate has been observed in association with kidney failure and uremic coma
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(see Chap. 38). The chemical basis of the functional and metabolic disturbances in the brain in
this condition also remains undetermined.
In the comatose states associated with these
systemic metabolic diseases, there is depression of
both conscious mental activity and cerebral energy metabolism. From the available evidence, it
is impossible to distinguish which, if either, is the
primary change. It is more likely that the depressions of both functions, although well correlated
with each other, are independent reflections of a
more general impairment of neuronal processes
by some unknown factors incident to the disease.

Measurement of local cerebral energy
metabolism in humans
Most of the in vivo measurements of cerebral energy metabolism described above, and all of those
in humans, were made in the brain as a whole
and represent the mass-weighted average of the
metabolic activities in all of the component
structures of the brain. The average, however, often obscures transient and local events in the individual components, and it is not surprising that
many of the studies of altered cerebral function,
both normal and abnormal, have failed to
demonstrate corresponding changes in energy
metabolism (see Table 31-8). The [ 14 C]deoxyglucose method [19] has made it possible to
measure glucose utilization simultaneously in all
of the components of the central nervous system,
and it has been used to identify regions withaltered functional and metabolic activities in a variety of physiological, pharmacological and
pathological states [21]. As originally designed,
the method utilized autoradiography of brain
sections for localization, which precluded its use
in humans. However, later developments with
PET [40] made it possible to adapt it for human
use, which is described fully in Chapter 54.
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